These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12145798)

  • 21. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Turner D; Ricciuto A; Lewis A; D'Amico F; Dhaliwal J; Griffiths AM; Bettenworth D; Sandborn WJ; Sands BE; Reinisch W; Schölmerich J; Bemelman W; Danese S; Mary JY; Rubin D; Colombel JF; Peyrin-Biroulet L; Dotan I; Abreu MT; Dignass A;
    Gastroenterology; 2021 Apr; 160(5):1570-1583. PubMed ID: 33359090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis.
    Li C; Ng JK; Chan GC; Fung WW; Lai KB; Poon PY; Luk CC; Chow KM; Szeto CC
    Clin Kidney J; 2024 Mar; 17(3):sfae056. PubMed ID: 38516523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Management for Pediatric Irritable Bowel Syndrome: A Review.
    Alyasi AS; Altawili MA; Alabbadi AF; Hamdi AHA; Alshammery AS; Alfahad MI; Alamri RM; Alanazi TR; Harbi MHA; Alajmi AM; Alabdulrahim JM; Alalshaikh AM; Hanbzazah AM
    Cureus; 2023 Nov; 15(11):e49197. PubMed ID: 38130553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal calprotectin level is nonlinearly associated with GI pathogen detection in patients with and without inflammatory bowel disease.
    Newman KL; Higgins PDR
    J Clin Microbiol; 2023 Dec; 61(12):e0094623. PubMed ID: 38038481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide
    Rella S; Onyiah J; Baker C; Singh V; Her A; Rasouli N
    Ther Adv Endocrinol Metab; 2023; 14():20420188231207348. PubMed ID: 37916028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review.
    Asiri AS; Algarni SS; Althubaiti AQ; Alzubaidi MA; Alghamdi JA; Almalki GA
    Cureus; 2023 Sep; 15(9):e45019. PubMed ID: 37829963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis.
    Tursi A; Piovani D; Brandimarte G; Di Mario F; Elisei W; Picchio M; Allegretta L; Annunziata ML; Bafutto M; Bassotti G; Bianco MA; Colucci R; Conigliaro R; Dumitrascu DL; Escalante R; Ferrini L; Forti G; Franceschi M; Graziani MG; Lammert F; Latella G; Maconi G; Compare D; Nardone G; Camara De Castro Oliveira L; Oliveira EC; Papa A; Papagrigoriadis S; Pietrzak A; Pontone S; Poskus T; Pranzo G; Reichert MC; Rodinò S; Regula J; Scaccianoce G; Scaldaferri F; Vassallo R; Zampaletta C; Zullo A; Spaziani E; Bonovas S; Danese S;
    United European Gastroenterol J; 2023 Sep; 11(7):642-653. PubMed ID: 37550901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases.
    Kapel N; Ouni H; Benahmed NA; Barbot-Trystram L
    Clin Transl Gastroenterol; 2023 Sep; 14(9):e00617. PubMed ID: 37440723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of urinary calprotectin as a novel marker differentiating functional from structural acute kidney injury in the critical care setting.
    John JS; Deepthi RV; Rebekah G; Prabhu SB; Ajitkumar P; Mathew G; Agarwal I
    J Nephrol; 2023 Apr; 36(3):695-704. PubMed ID: 36809659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study.
    Li M; Zhang R; Xin M; Xu Y; Liu S; Yu B; Zhang B; Liu J
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt™ proteome microarray.
    Fan W; Fang X; Hu C; Fei G; Xiao Q; Li Y; Li X; Wood JD; Zhang X
    Front Physiol; 2022; 13():1010069. PubMed ID: 36262261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease.
    Pavlidis P; Joshi D; El Sherif Y; Warner B; Gulati S; Alexander J; Cross G; Dew T; Arqoub HA; Devlin J; Heneghan M; Dubois P; Bjarnason I; Powell N; Hayee B
    Frontline Gastroenterol; 2022; 13(6):497-502. PubMed ID: 36250171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn's Disease.
    Lee YJ; Park JH
    Pediatr Gastroenterol Hepatol Nutr; 2022 Sep; 25(5):396-405. PubMed ID: 36148291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis.
    Ross FA; Park JH; Mansouri D; Combet E; Horgan PG; McMillan DC; Roxburgh CSD
    BMC Gastroenterol; 2022 Apr; 22(1):176. PubMed ID: 35397505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study.
    Blad N; Palmqvist R; Karling P
    BMC Cancer; 2022 Mar; 22(1):315. PubMed ID: 35331198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis.
    Nasir Kansestani A; Zare ME; Tong Q; Zhang J
    Sci Rep; 2022 Feb; 12(1):2623. PubMed ID: 35173276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis.
    Sasidharan S; Sasson AN; Shannon KM; Ananthakrishnan AN
    Inflamm Bowel Dis; 2022 Dec; 28(12):1833-1837. PubMed ID: 35134899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-and post-treatment evaluation of intestinal inflammation in
    Ibrahim HS; Salem AI; Ahmed NMAE; El-Taweel HA
    J Parasit Dis; 2021 Dec; 45(4):1026-1033. PubMed ID: 34789986
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disorders.
    Moorman EL; Farrell M; Santucci N; Denson L; Le C; Cunningham NR
    BMC Res Notes; 2021 Sep; 14(1):360. PubMed ID: 34526124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.